E-Articles - Health and Fitness

We cannot discuss obesity in the same terms when it deals with children as it relates

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

to adults. Some researchers avoid the word “obesity” altogether in an effort to avoi

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

d stigmatizing individuals. Others use the term “childhood obesity” to speak of a gen

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

eral phenomenon. Nevertheless, obesity is indeed a problem among young people, no mat

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ter what terminology you choose to employ.

Besides the obvious psychological issues

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

that children afflicted with obesity often have to deal with, childhood obesity can c

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ause numerous physical health problems. One of the biggest concerns in recent years h

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

s been the rising number of children afflicted with type 2 diabetes – a disease that

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

previously mainly afflicted adults.

In the course of the last two decades, the stati

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

stics of children and adult afflicted with this disease have risen to fifty percent.

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

Today, nearly thirty percent of all adults and twenty five percent of all children st

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ruggle with obesity.

What’s more, children who are obese often develop into obese ad

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ults. Parallel to the increase in obesity has been the increase in type 2 diabetes, a

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

lso known as non insulin dependent diabetes.

Throw obesity in to the equation, and t

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

is type of diabetes can be very difficult to treat. It can even cause the body to dev

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

elop an insulin resistance.

Diabetes 2 is not the only physical health issue related

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

to obesity. People who are overweight and/or obese are at major risk for contacting

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

severe chronic diseases such as cancer, cardiovascular disease, osteoporosis, and hyp

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ertension. For children afflicted with severe weight problems, they can contact gall

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

bladder disease, liver disease, sleep apnea, and may run the risk of high cholesterol

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/261491/e-article-Child-Obesity-and-Diabetes.html">Child Obesity and Diabetes</a>

BB link (for phorums):
[url=http://www.e-article.org.ua/article/261491/e-article-Child-Obesity-and-Diabetes.html]Child Obesity and Diabetes[/url]

Without sales or customers, even if you are giving the product or service away, there's no reason to be there.

How does debt creep up on us? How do we fight debt once we have it? Ways to fight bankruptcy and how to avoid the debt trap.

Some men say they cannot live with women and they cannot live without women. I think they mean they do not understand women. Women are God's third most important gift, following the gift of life and the gift of free will. Since women are a necessary and wonderful addition to a man's world here are 14 things that every woman should know about men and why some men are more interesting than others. Part 3 of 3 Parts.

Tags

Links

E-Articles - Child Obesity and Diabetes

Related Articles: